Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 1,063,348 |
|
|||||
| News | - | ||||||
| Day High | 29.86 | Low High |
|||||
| Day Low | 28.54 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Immunovant Inc | IMVT | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.04 | -0.14% | 28.70 | 18:58:13 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 28.94 | 28.54 | 29.86 | 28.61 | 28.74 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 14,921 | 1,063,348 | $ 29.18 | $ 31,032,047 | - | 15.33 - 45.58 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:58:13 | 12 | $ 28.70 | USD |
Immunovant (IMVT) Options Flow Summary
Immunovant Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 4.17B | 145.29M | - | 0 | -210.96M | -1.45 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Immunovant News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical IMVT Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 29.80 | 30.96 | 27.33 | 28.73 | 1,186,163 | -1.10 | -3.69% |
| 1 Month | 31.34 | 33.13 | 27.33 | 30.35 | 1,044,767 | -2.64 | -8.42% |
| 3 Months | 38.73 | 39.55 | 27.33 | 33.35 | 1,174,837 | -10.03 | -25.90% |
| 6 Months | 33.88 | 45.58 | 27.33 | 36.45 | 1,366,453 | -5.18 | -15.29% |
| 1 Year | 15.54 | 45.58 | 15.33 | 32.02 | 1,497,577 | 13.16 | 84.68% |
| 3 Years | 15.94 | 45.58 | 3.145 | 20.48 | 1,061,562 | 12.76 | 80.05% |
| 5 Years | 15.88 | 53.75 | 3.145 | 21.61 | 910,774 | 12.82 | 80.73% |
Immunovant Description
| Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes IMVT-1401 targets the neonatal Fc receptor (FcRn). |
